Fathema Uddin
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
Papers in
-
- RNA modifications and cancer 2
- CRISPR and Genetic Engineering 2
- Epigenetics and DNA Methylation 1
- Cancer therapeutics and mechanisms 1
- Oncology 3
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 1
- Co-authors
- Triparna Sen (6 shared papers)Charles M. Rudin (6 shared papers)Nisargbhai Shah (4 shared papers)Elisa de Stanchina (4 shared papers)Marı́a Contel (1 shared paper)Benelita T. Elie (1 shared paper)Àlvaro Quintanal-Villalonga (4 shared papers)Omar Hayatt (2 shared papers)
- Journals
- Cell Reports (2 papers)Frontiers in Oncology (1 paper)JBIC Journal of Biological Inorganic Chemistry (1 paper)Journal of Thoracic Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Fathema Uddin
7 papers receiving 786 citations
Fathema Uddin's Hit Papers
Peers
Comparison fields: 5 of 87
- Business and International Management 38
- Oncology 224
- Aging 15
- Molecular Biology 491
- Cancer Research 97
Countries citing papers authored by Fathema Uddin
This map shows the geographic impact of Fathema Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fathema Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fathema Uddin more than expected).
Fields of papers citing papers by Fathema Uddin
This network shows the impact of papers produced by Fathema Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fathema Uddin. The network helps show where Fathema Uddin may publish in the future.
Co-authors
The 25 scholars most cited alongside Fathema Uddin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future Hit paper breakdown → | 2020 | 401 |
| 2 | 2020 | 167 | |
| 3 | 2022 | 87 | |
| 4 | 2022 | 83 | |
| 5 | 2018 | 58 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 2 |
About Fathema Uddin
Fathema Uddin is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 800 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (2 papers), RNA modifications and cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer Mechanisms and Therapy (1 paper), Click Chemistry and Applications (1 paper), Epigenetics and DNA Methylation (1 paper), Cancer therapeutics and mechanisms (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Business and International Management (38 citations), Oncology (224 citations), Aging (15 citations), Molecular Biology (491 citations) and Cancer Research (97 citations). Fathema Uddin has collaborated with scholars based in United States and Japan. Frequent co-authors include Triparna Sen, Charles M. Rudin, Nisargbhai Shah, Elisa de Stanchina, Marı́a Contel, Benelita T. Elie, Àlvaro Quintanal-Villalonga, Omar Hayatt, Kathryn C. Arbour and Hirokazu Taniguchi. Their work appears in journals such as Cell Reports, Frontiers in Oncology, JBIC Journal of Biological Inorganic Chemistry, Journal of Thoracic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.